Identification of Mediterranean mutation in Egyptian favism patients

Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2821-7.

Abstract

Objectives: Identify and screen the G6PD Mediterranean mutation in favism patients by applying a Amplification Refractory Mutation System Polymerase Chain Reaction (ARMS-PCR).

Patients and methods: A total of 114 unrelated Egyptians patients were included in the present study; their ages ranged between (2-9) years with male to female ratio 4.5:1. G6PD activity was determined qualitatively from red cell hemolysate during attack. The G6PD Mediterranean mutation in patients has been identified by ARMS-PCR.

Results: G6PD deficiency was detected in 87.7%, (n=100). The frequency of G6PD Mediterranean mutation was (94.7%), (n=108). The association between G6PD deficiency and Mediterranean mutation was a highly significant.

Conclusions: Glucose-6-phosphate dehydrogenase Mediterranean mutation is one of the most common mutations causing G6PD deficiency among Egyptian children with favism.

MeSH terms

  • Case-Control Studies
  • Child
  • Child, Preschool
  • Egypt
  • Favism / enzymology
  • Favism / genetics*
  • Female
  • Glucosephosphate Dehydrogenase / blood
  • Glucosephosphate Dehydrogenase / genetics*
  • Glycation End Products, Advanced
  • Humans
  • Male
  • Mutation*
  • Polymerase Chain Reaction / methods

Substances

  • Glycation End Products, Advanced
  • Glucosephosphate Dehydrogenase